T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
AGN
Allergan plc
AGN
|
$1.71B |
| 2 |
Becton Dickinson
BDX
|
$780M |
| 3 |
Ashland
ASH
|
$727M |
| 4 |
Canadian Natural Resources
CNQ
|
$694M |
| 5 |
Keysight
KEYS
|
$593M |
Top Sells
| 1 |
RTX Corp
RTX
|
$1.83B |
| 2 |
Ecolab
ECL
|
$1.12B |
| 3 |
Crown Castle
CCI
|
$890M |
| 4 |
Phillips 66
PSX
|
$753M |
| 5 |
Gilead Sciences
GILD
|
$689M |
Sector Composition
| 1 | Healthcare | 19.84% |
| 2 | Consumer Discretionary | 13.93% |
| 3 | Financials | 13.41% |
| 4 | Industrials | 12.29% |
| 5 | Technology | 9.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
301
Brunswick
BC
$4.35B
| $358M | 0.08% |
6,990,285
-367,826
| -5% | -$18.9M |
|
302
GSK
GSK
$81.5B
| $358M | 0.08% |
6,702,530
+40,376
| +0.6% | +$2.16M |
|
303
Accenture
ACN
$159B
| $357M | 0.08% |
4,002,475
-286,381
| -7% | -$25.6M |
|
304
ConocoPhillips
COP
$116B
| $357M | 0.08% |
5,172,777
-129,530
| -2% | -$8.95M |
|
305
Ball Corp
BALL
$13.9B
| $356M | 0.08% |
10,447,062
-527,150
| -5% | -$18M |
|
306
Viavi Solutions
VIAV
$2.6B
| $355M | 0.08% |
45,549,898
-132,393
| -0.3% | -$1.03M |
|
307
Analog Devices
ADI
$122B
| $352M | 0.07% |
6,347,731
-762,480
| -11% | -$42.3M |
|
308
Teva Pharmaceuticals
TEVA
$21.7B
| $350M | 0.07% |
6,084,706
+755,668
| +14% | +$43.5M |
|
309
Essex Property Trust
ESS
$17.3B
| $349M | 0.07% |
1,690,698
+3,185
| +0.2% | +$658K |
|
310
Rayonier
RYN
$4.12B
| $349M | 0.07% |
13,126,804
+9,586,565
| +271% | +$255M |
|
311
Genuine Parts
GPC
$19.4B
| $347M | 0.07% |
3,255,601
+20,210
| +0.6% | +$2.15M |
|
|
WFM
312
DELISTED
Whole Foods Market Inc
WFM
| $345M | 0.07% |
6,833,707
-407,602
| -6% | -$20.6M |
|
|
CB
313
DELISTED
CHUBB CORPORATION
CB
| $341M | 0.07% |
3,296,445
+29,861
| +0.9% | +$3.09M |
|
314
Equity Residential
EQR
$25.5B
| $341M | 0.07% |
4,747,775
+14
| +0% | +$1.01K |
|
315
Zillow
ZG
$20.5B
| $341M | 0.07% |
9,656,520
+5,573,283
| +136% | +$197M |
|
|
DGI
316
DELISTED
DigitalGlobe Inc.
DGI
| $339M | 0.07% |
10,959,983
-2,451,200
| -18% | -$75.9M |
|
317
Ford
F
$46.7B
| $339M | 0.07% |
21,861,227
+427,750
| +2% | +$6.63M |
|
318
RH
RH
$4.7B
| $338M | 0.07% |
3,525,329
-1,421,073
| -29% | -$136M |
|
|
CVD
319
DELISTED
COVANCE INC.
CVD
| $338M | 0.07% |
3,252,502
-1,223,319
| -27% | -$127M |
|
320
Federal Realty Investment Trust
FRT
$8.86B
| $334M | 0.07% |
2,503,076
-78,495
| -3% | -$10.5M |
|
321
Liberty Global Class A
LBTYA
$4.05B
| $332M | 0.07% |
8,019,288
+1,872,520
| +30% | +$77.5M |
|
322
Stratasys
SSYS
$871M
| $331M | 0.07% |
3,980,047
-549,639
| -12% | -$45.7M |
|
323
C.H. Robinson
CHRW
$14.9B
| $330M | 0.07% |
4,404,989
-158,165
| -3% | -$11.8M |
|
324
Delta Air Lines
DAL
$39.9B
| $328M | 0.07% |
6,659,117
-7,597,319
| -53% | -$374M |
|
325
McCormick & Company Non-Voting
MKC
$19B
| $327M | 0.07% |
8,808,782
+42,264
| +0.5% | +$1.57M |
|